.jpg?#)
NMDC Q3 Review: Systematix Raises Target Price Amid Long-Term Growth Outlook
Systematix remain positive on NMDC based on a robust medium to long term growth outlook and retains its FY28 estimates.
Systematix remain positive on NMDC based on a robust medium to long term growth outlook and retains its FY28 estimates.
What's Your Reaction?
